RecruitingNot ApplicableNCT04207814

Determinants of Repeated Spontaneous Miscarriages and Unexplained Fetal Deaths

Determinants of Repeated Spontaneous Miscarriages and Unexplained Fetal Deaths (DEFI-2)


Sponsor

University Hospital, Brest

Enrollment

200 participants

Start Date

Oct 5, 2020

Study Type

INTERVENTIONAL

Conditions

Summary

The DEFI-1 study recruited 625 women witnesses and 299 of their spouses. With regard to case couples, 271 cases were recruited from the spontaneous repeated miscarriages (SRM) subgroup (≥3 spontaneous miscarriage (SM) from trimester 1 of pregnancy) and 93 from the unexplained fetal death in utero (FDIU) subgroup from trimesters 2 and 3 of pregnancy. The main objective of the DEFI 2 study is to increase the number of case-pairs in these 2 particular subgroups to replicate the results of the genetic determinants highlighted from cases and controls with extreme phenotypes and obtain a sufficient number of women with FDIUs to identify specific determinants.


Eligibility

Min Age: 18 YearsMax Age: 40 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying biological sample for people with fetal deaths in utero and repeated spontaneous miscarriages. The study is currently recruiting participants at 1 location.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

BIOLOGICALbiological sample

biological samples will be taken from the subjects included


Locations(1)

BREST

Brest, France

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT04207814